i2O Therapeutics
PrivateLast Round
Series A
Aug 28, 2023
Total Funding Raised
$50.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
i2O Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in August 2023.
i2O Therapeutics is a biotechnology company that develops oral formulations of therapies traditionally limited to injections using proprietary ionic liquid technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i2O Therapeutics Comparables
Compare i2O Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivtex | 91% | |
| Cyprumed GmbH | 86% | |
| Rani Therapeutics | 82% |
For institutional investors. Book with your work email.
i2O Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2023 | ||||
| Seed | Dec 3, 2020 | ||||
| Seed | Apr 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
i2O Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cerity Partners Ventures | Series A |
| HM Venture Partners | Series A |
| Colorcon Ventures | Series A, Seed |
| Sanofi Ventures | Series A, Seed |
| JDRF | Seed |
| 7G Bioventures | Series A |
| Hikma Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 255% MoM, from 419 to 1.5K.
- Apr 20, 2026
Monthly visitors grew 143% MoM, reaching 657.
For institutional investors. Book with your work email.
i2O Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about i2O Therapeutics's valuation, stock price, and market status.
Is i2O Therapeutics a public or private company?
i2O Therapeutics is a private company.
What is the current stock price of i2O Therapeutics?
i2O Therapeutics is a private company, so its shares have no public market price. Caplight tracks i2O Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is i2O Therapeutics worth (valuation)?
Valuation information for i2O Therapeutics is not publicly available.
Can I buy i2O Therapeutics stock?
i2O Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was i2O Therapeutics's last funding round?
i2O Therapeutics's most recent funding round was Series A on August 28, 2023.
Who are the main investors in i2O Therapeutics?
Key investors in i2O Therapeutics include Colorcon Ventures, Sanofi Ventures, JDRF.
Will i2O Therapeutics IPO soon?
No public IPO plans have been announced for i2O Therapeutics.
How can I track i2O Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in i2O Therapeutics's shares on secondary markets.